Dr. Bowens is the recipient of a 2007 Children’s Medical Center Foundation CCRAC (Children’s Clinical Research Advisory Committee) grant for a study titled Phase I Trial to Determine Steady State Pharmacokinetics and Sedative Effects of Low Dose Ketamine Infusion. She is also site PI for a NIH U10 Cooperative Clinical Research grant.
Alice Chang, MD, MSCS, an Assistant Professor in Internal Medicine, earned her medical degree from the Yale University School of Medicine. She graduated from the Clinical Research Scholars program in May, 2008 with a Master’s of Science Degree in Clinical Science with Distinction.
In 2007, she received an American Heart Association Fellow-to-Faculty Transition Award for her project titled Coronary Altherosclerosis and CV Performance in Polycystic Ovarian Syndrome. Dr. Chang is also the recipient of a 2007 UT Southwestern Department of Clinical Sciences Pilot Award. In Spring, 2008 she received an NCTCTSI Pilot Grant for her research project titled The Effect of Exercise Training on Coronary Vascular Reactivity and Cardiovascular Performance in Women with Androgen Excess Disorders.
Randall Friese, MD, MSCS is an Associate Professor at the University of Arizona HSC Department of Surgery in Tucson, Arizona. He earned his medical degree from the University of Maryland School of Medicine and graduated from the UT Southwestern Clinical Research Scholars program in May, 2008 with a Master’s of Science Degree in Clinical Science with Distinction.
In 2007, he received a UT Southwestern Department of Clinical Sciences Pilot Award for a pilot study on the Effects of Sleep Deprivation and Benefits of Sleep Promotion during Recovery from Critical Illness and Injury.
Subroto Ghose, MD, PhD, MSCS, Assistant Professor in Psychiatry, earned his M.D. degree from Maulana Azad Medical College, New Delhi, India, followed by his Ph.D. in biology from Georgetown University. He graduated from the Clinical Research Scholars program in May, 2008 with a Master’s of Science Degree in Clinical Science with Distinction.
Dr Ghose is the recipient of a two-year NARSAD 2007 Young Investigator Award for a project titled The Role of N-acetylaspartylglutamate (NAAG) in Schizophrenia. In 2007, he received a five-year NIH K08 Clinical Investigator Award for a research project titled Gene Environment Interaction in Schizophrenia, and in Spring, 2008, an NCTCTSI Pilot Award for his project Atomoxetine as an Adjunctive Medication in a Subgroup of Schizophrenia.
Heidi Jacobe, MD, MSCS, Assistant Professor in Dermatology, earned her medical degree from the Texas A&M HSC Baylor College of Medicine. She graduated from the Clinical Research Scholars program in May, 2008 with a Masters of Science Degree in Clinical Science with Distinction.
In 2007, Dr. Jacobe received a three-year Medical Dermatology Career Development Award for her research project titled Immunologic Profiles in Subsets of Morphea Patients from the Dermatology Foundation. The following year, she received a 5-year NIH K23 Mentored Patient-Oriented Research Career Development Award. In Spring, 2008, she received an NCTCTSI Pilot Award for a project titled Assessment in Morphea for Establishment of Non-Cutaneous Disease.
Janna Journeycake, MD, MSCS, Assistant Professor in Pediatrics, received her medical degree from the University of Oklahoma College of Medicine. She graduated from the Clinical Research Scholars program in May 2008 with a Masters of Science Degree in Clinical Science with Distinction.
She received a 5-year NIH K23 Mentored Patient-Oriented Research Career Development Award for a project titled Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in 2006.
Ildiko Lingvay, MD, MPH, MSCS, Assistant Professor in Internal Medicine, earned her medical degree from Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. She graduated from the Clinical Research Scholars program in May, 2008 with a Masters of Science Degree in Clinical Science with Distinction.
She received a 5-year NIH K23 Mentored Patient-Oriented Research Career Development Award for a project titled The Role of Pancreatic Triglycerides in Beta-Cell Dysfunction in 2006. Dr. Lingvay received a 2007 UT Southwestern Department of Clinical Sciences Pilot Award,followed in Spring 2008 by an NCTCTSI Pilot Award for a project titled Ectopic Fat Changes after Surgically-Induced Weight Loss: Does it Explain the Resolution of Diabetes?
Charles Quinn, MD, MSCS, Assistant Professor in Pediatrics, earned his medical degree from UT Southwestern and graduated from the Clinical Research Scholars program in May, 2008 with a Masters of Science Degree in Clinical Science with Distinction.
Dr. Quinn is the recipient of a 2008 3-year Children’s Medical Center Foundation CCRAC (Children’s Clinical Research Advisory Committee) grant for a pilot study titled Acute Bone Turnover and Disordered Porphyrin Metabolism as Novel Potential Mechanisms of Sickle Cell Pain. He serves as subproject PI and Sickle Cell Scholar Mentor for a 5-year NIH U54 Cooperative Agreement for the Southwestern Comprehensive Sickle Cell Center, Basic and Translational Research Program in Sickle Cell Disease. Dr. Quinn is also the site PI for four multi-center NIH R01 Research Project Grants.
Carlos Timaran, MD, MSCS, Assistant Professor in Surgery, earned his medical degree from the University of Cauca in Colombia and graduated from the Clinical Research Scholars program in May, 2008 with a Masters of Science Degree in Clinical Science with Distinction.
In 2007 he received a UT Southwestern Department of Clinical Sciences Pilot Award, followed in 2008 by a three-year American Heart AssociationScientist Development Grant for his research project Community-Based Detection and Treatment of Peripheral Arterial Disease in Hispanics Program.
Jane Wigginton, MD, Assistant Professor in Surgery/Emergency Medicine, received her medical degree from UT Southwestern.
In 2006, Dr. Wigginton received a UT Southwestern High Impact/High Risk Grant for a project titled Intravenous Bolus of Estrogen to Improve Outcomes Following Severe Traumatic Brain Injury. She recently received FDA approval for two USDA Investigational New Drug Applications. The first of these is titled Phase II Trial to Evaluate the Effects of a Single Dose of Intravenous Estrogen for the Treatment of Patients with Severe Traumatic Brain Injury. The second, titled Non Interventional F Two - Isoprostane Study-Traumatic Brain Injury (NIFTI - TBI) And Resuscitative Endocrinology: Single dose Clinical Uses for Estrogen Rats-Traumatic Brain Injury (RESCUE Rats TBI), includes pilot research funded by a Spring, 2008 NCTCTSI Pilot Award.
